Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24039709 | 0.96 | AHR (0.35) | AHRALOX5KDM4EALDH1A1HPGD | |
| SCHEMBL25068743 | 0.94 | AHR (0.36) | AHRALOX5KDM4EALDH1A1HPGD | |
| SCHEMBL24039364 | 0.94 | CHEK2 (0.34) | AHRALOX5KDM4EALDH1A1HPGD | |
| SCHEMBL24794920 | 0.93 | ALOX5 (0.33) | AHRALOX5KDM4EALDH1A1HPGD | |
| SCHEMBL24039677 | 0.92 | AHR (0.33) | AHRALOX5KDM4EALDH1A1HPGD | |
| SCHEMBL24039487 | 0.92 | AHR (0.36) | AHRALOX5KDM4EALDH1A1HPGD | |
| SCHEMBL24039579 | 0.91 | MMP12 (0.33) | AHRALOX5KDM4EALDH1A1HPGD | |
| SCHEMBL24039173 | 0.91 | KDM4E (0.36) | AHRALOX5KDM4EALDH1A1HPGD | |
| SCHEMBL24039217 | 0.91 | KDM4E (0.36) | AHRALOX5KDM4EALDH1A1HPGD | |
| SCHEMBL24039860 | 0.91 | PDK2 (0.33) | KDM4EALDH1A1HPGDMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11183641-B2 | Composition for an organic electronic device and organic electronic device using the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2021-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11183641-B2 | Composition for an organic electronic device and organic electronic device using the same | ORC3, ZYX, ESR1 | AHR 653/4885ALOX5 2066/4885KDM4E 1354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.